An AllTrials project

NCT04292899: A reported trial by Gilead Sciences

This trial has reported on time, in line with the regulations.

Full data

Full entry on ClinicalTrials.gov NCT04292899
Title A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe COVID-19
Results Status Reported
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date March 6, 2020
Completion date April 9, 2020
Required reporting date April 9, 2021, midnight
Actual reporting date Dec. 15, 2020
Date last checked at ClinicalTrials.gov Jan. 13, 2022
Days late None